Neuropace, Inc. NPCE Convertible Preferred Stock Outstanding Shares
Convertible Preferred Stock Outstanding Shares at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s convertible preferred stock outstanding shares.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s convertible preferred stock outstanding shares?
- Neuropace, Inc. (NPCE) reported convertible preferred stock outstanding shares of 0 in Q1 2026.
- What does convertible preferred stock outstanding shares mean?
- This represents the total number of preferred equity shares that carry the right to be converted into common stock at a predetermined ratio. It is a critical metric for calculating fully diluted earnings per share and understanding potential future equity dilution. Investors track this to evaluate the impact of capital structure changes on existing shareholder value.